Home | Cognision
Overview
Cognision is a company in the neurotech sector based in Boston, Massachusetts. It develops the COGNISION® System, which is an FDA-cleared, cloud-powered EEG/ERP system designed for neurocognitive biomarkers and assessment. This system helps clinicians evaluate patients with conditions such as dementia and concussion/mTBI. The COGNISION® System has been used in various clinical trials to enhance the application of precision EEG/ERP biomarkers in central nervous system drug development. Additionally, Cognision offers COGNISION360™, an integrated platform that combines EEG, event-related potentials, polysomnography, eye tracking, wearable sensors, cognitive assessments, and electronic clinical outcome assessments for use in CNS clinical trials. The company is also a founding member of the EEG/ERP Biomarker Qualification Consortium.
Details
- Category
- Biotechnology Research
- Headquarters
- Boston, Massachusetts
- Type
- Privately Held
- Followers
- 1,174
- Specialties
- EEG, Electroencephalography, Biomarkers, Digital Health, Neuroscience, Neuropsychiatry, Neurology, Psychiatry, Mental Health, Depression, Schizophrenia, Concussion, Traumatic Brain Injury, Dementia, Alzheimer's Disease, Mild Cognitive Impairment, Memory Disorders, Clinical Research, Clinical Trials, and Drug Development
- Locations
- Boston, Massachusetts, US
1044 E. Chestnut St. Louisville, Kentucky 40204, US